Episode 12: SGLT2 Inhibitors - A Cardiac vs Renal Perspective

In this episode, we are joined by Internal Medicine PGY-3s and soon-to-be fellows Dr. Carrie Mahurin and Dr. Jen Bergeron. Together, they review the evidence for or against a broadened therapeutic role of SGLT2 Inhibitors beyond diabetes treatment, in light of new trials suggesting efficacy in heart failure and chronic kidney disease management.

 

Guests: Dr. Carrie Mahurin, MD, PGY3 at UVMMC, and Dr. Jen Bergeron, MD, PGY3 at UVMMC

 

Thumbnail by Kate Hliznitsova on Unsplash